World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
25415
World Ranking
10621
National Ranking
5458

Overview

David A. Mankoff is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on the field of Medicine, with a significant concentration on Radiology, Nuclear Medicine and Imaging, Cancer Research, Pulmonary and Respiratory Medicine, Oncology, and Epidemiology. Within these areas, their work addresses topics related to Medical Imaging Techniques and Applications, Radiomics and Machine Learning in Medical Imaging, Radiopharmaceutical Chemistry and Applications, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer, Hypoxia, and Metabolism, and Prostate Cancer Treatment and Research.

Mankoff has contributed to several recent scientific papers. Notable publications include:

  • The Future of Nuclear Medicine, Molecular Imaging, and Theranostics, 2020, Journal of Nuclear Medicine
  • Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-18F-Fluoro-17β-Fluoroestradiol, 2023, Journal of Nuclear Medicine
  • Quantitative PET in the 2020s: a roadmap, 2020, Physics in Medicine and Biology
  • The role of resting myocardial blood flow and myocardial blood flow reserve as a predictor of major adverse cardiovascular outcomes, 2020, PLoS ONE
  • Positron Emission Tomography Imaging of Poly-(Adenosine Diphosphate-Ribose) Polymerase 1 Expression in Breast Cancer, 2020, JAMA Oncology

The scientist frequently publishes in several venues, including:

  • Journal of Nuclear Medicine
  • Journal of Clinical Oncology
  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Cancer Research

Collaborations have been established with multiple frequent co-authors, namely:

  • Austin R. Pantel
  • Mark Muzi
  • Lanell M. Peterson
  • Hannah M. Linden
  • Robert K. Doot

Best Publications

  • Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

    Gary J. Kelloff;John M. Hoffman;Bruce Johnson;Howard I. Scher

  • Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials

    Lalitha K. Shankar;John M. Hoffman;Steve Bacharach;Michael M. Graham

  • Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.

    Laurie L. Carr;David A. Mankoff;Bernardo H. Goulart;Keith D. Eaton

  • Quantitative Fluoroestradiol Positron Emission Tomography Imaging Predicts Response to Endocrine Treatment in Breast Cancer

    Hannah M. Linden;Svetlana A. Stekhova;Jeanne M. Link;Julie R. Gralow

  • Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.

    Joseph G. Rajendran;David A. Mankoff;Finbarr O'Sullivan;Lanell M. Peterson

  • Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer

    Hans-Anton Lehr;David A. Mankoff;David Corwin;Guiseppe Santeusanio

  • Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology

    John Kurhanewicz;Daniel B Vigneron;Jan Henrik Ardenkjaer-Larsen;James A Bankson

  • A definition of molecular imaging

    David A Mankoff

  • Blood Flow and Metabolism in Locally Advanced Breast Cancer: Relationship to Response to Therapy

    David A. Mankoff;Lisa K. Dunnwald;Julie R. Gralow;Georgiana K. Ellis

  • Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography.

    Lucy Sasongko;Jeanne M. Link;Mark Muzi;David A. Mankoff

  • Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol

    Lanell M. Peterson;David A. Mankoff;Thomas Lawton;Kevin Yagle

  • ACR Appropriateness Criteria Breast Cancer Screening

    Martha B. Mainiero;Ana Lourenco;Mary C. Mahoney;Mary S. Newell

  • FDG PET, PET/CT, and Breast Cancer Imaging

    Eric L Rosen;William B Eubank;David A Mankoff

  • Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy

    David A. Mankoff;Lisa K. Dunnwald;Julie R. Gralow;Georgiana K. Ellis

  • The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development

    Gary J. Kelloff;Kenneth A. Krohn;Steven M. Larson;Ralph Weissleder

  • Continuous-slice PENN-PET: a positron tomograph with volume imaging capability.

    Joel S. Karp;Gerd Muehllehner;David A. Mankoff;Caesar E. Ordonez

  • 18Fluorodeoxyglucose Positron Emission Tomography to Detect Mediastinal or Internal Mammary Metastases in Breast Cancer

    W. B. Eubank;D. A. Mankoff;J. Takasugi;H. Vesselle

  • PET/CT imaging in cancer: current applications and future directions.

    Michael D. Farwell;Daniel A. Pryma;David A. Mankoff

  • Cancer biomarkers: a systems approach

    Leland H. Hartwell;David Mankoff;Amanda Paulovich;Scott Ramsey;Scott Ramsey

  • Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and

    Lanell M. Peterson;David A. Mankoff;Thomas Lawton;Kevin Yagle

Frequent Co-Authors

Kenneth A. Krohn
Kenneth A. Krohn Oregon Health & Science University
Paul E. Kinahan
Paul E. Kinahan University of Washington
Robert H. Mach
Robert H. Mach University of Pennsylvania
Julie R. Gralow
Julie R. Gralow American Society of Clinical Oncology
Joel S. Karp
Joel S. Karp University of Pennsylvania
Robert B. Livingston
Robert B. Livingston University of Arizona
Jashvant D. Unadkat
Jashvant D. Unadkat University of Washington
Gerd Muehllehner
Gerd Muehllehner University of Pennsylvania
Constance D. Lehman
Constance D. Lehman Harvard University
William E. Barlow
William E. Barlow Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare careers beyond studying Medicine in the USA, there are many online degree options that offer great flexibility and a range of career opportunities. Some students choose to start their journey by pursuing a BSN. Finding the easiest bsn program to get into can be an excellent first step towards a career as a registered nurse.

For those looking for quick entry into the healthcare industry without committing to a full nursing program, medical billing and coding is a popular option. You may want to explore medical billing and coding schools that accept fafsa, making these programs more financially accessible.

Becoming a Licensed Practical Nurse (LPN) is another fast-track option. Some schools are more accessible, such as an lpn school without teas test requirement, helping students get started faster.

If you’re interested in leadership and management within healthcare, consider enrolling in one of the healthcare administration degrees offered online. These programs prepare you for critical roles overseeing hospitals and medical offices.

Best Scientists Citing David A. Mankoff

Trending Scientists